Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency

Michael F Hammer, Ryan Sprissler, Robert W. Bina, Branden Lau, Laurel Johnstone, Christina M. Walter, David M Labiner, Martin E Weinand

Research output: Contribution to journalArticle

Abstract

Despite recent advances in our understanding of synaptic transmission associated with epileptogenesis, the molecular mechanisms that control seizure frequency in patients with temporal lobe epilepsy (TLE) remain obscure. RNA-Seq was performed on hippocampal tissue resected from 12 medically intractable TLE patients with pre-surgery seizure frequencies ranging from 0.33 to 120 seizures per month. Differential expression (DE) analysis of individuals with low (LSF, mean = 4 seizure/month) versus high (HSF, mean = 60 seizures/month) seizure frequency identified 979 genes with ≥2-fold change in transcript abundance (FDR-adjusted p-value ö0.05). Comparisons with post-mortem controls revealed a large number of downregulated genes in the HSF (1676) versus LSF (399) groups. More than 50 signaling pathways were inferred to be deactivated or activated, with Signal Transduction as the central hub in the pathway network. While neuroinflammation pathways were activated in both groups, key neuronal system pathways were systematically deactivated in the HSF group, including calcium, CREB and Opioid signaling. We also infer that enhanced expression of a signaling cascade promoting synaptic downscaling may have played a key role in maintaining a higher seizure threshold in the LSF cohort. These results suggest that therapeutic approaches targeting synaptic scaling pathways may aid in the treatment of seizures in TLE.

Original languageEnglish (US)
Article number106145
JournalEpilepsy Research
Volume155
DOIs
StatePublished - Sep 1 2019

Fingerprint

Temporal Lobe Epilepsy
Seizures
Synaptic Transmission
Opioid Analgesics
Genes
Signal Transduction
Down-Regulation
RNA
Calcium
Therapeutics

Keywords

  • Hippocampus
  • Pathway analysis
  • RNA-seq
  • Seizure frequency
  • Temporal lobe epilepsy

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency. / Hammer, Michael F; Sprissler, Ryan; Bina, Robert W.; Lau, Branden; Johnstone, Laurel; Walter, Christina M.; Labiner, David M; Weinand, Martin E.

In: Epilepsy Research, Vol. 155, 106145, 01.09.2019.

Research output: Contribution to journalArticle

@article{1b8e156ae3f340a69af3547b1359f5e4,
title = "Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency",
abstract = "Despite recent advances in our understanding of synaptic transmission associated with epileptogenesis, the molecular mechanisms that control seizure frequency in patients with temporal lobe epilepsy (TLE) remain obscure. RNA-Seq was performed on hippocampal tissue resected from 12 medically intractable TLE patients with pre-surgery seizure frequencies ranging from 0.33 to 120 seizures per month. Differential expression (DE) analysis of individuals with low (LSF, mean = 4 seizure/month) versus high (HSF, mean = 60 seizures/month) seizure frequency identified 979 genes with ≥2-fold change in transcript abundance (FDR-adjusted p-value {\"o}0.05). Comparisons with post-mortem controls revealed a large number of downregulated genes in the HSF (1676) versus LSF (399) groups. More than 50 signaling pathways were inferred to be deactivated or activated, with Signal Transduction as the central hub in the pathway network. While neuroinflammation pathways were activated in both groups, key neuronal system pathways were systematically deactivated in the HSF group, including calcium, CREB and Opioid signaling. We also infer that enhanced expression of a signaling cascade promoting synaptic downscaling may have played a key role in maintaining a higher seizure threshold in the LSF cohort. These results suggest that therapeutic approaches targeting synaptic scaling pathways may aid in the treatment of seizures in TLE.",
keywords = "Hippocampus, Pathway analysis, RNA-seq, Seizure frequency, Temporal lobe epilepsy",
author = "Hammer, {Michael F} and Ryan Sprissler and Bina, {Robert W.} and Branden Lau and Laurel Johnstone and Walter, {Christina M.} and Labiner, {David M} and Weinand, {Martin E}",
year = "2019",
month = "9",
day = "1",
doi = "10.1016/j.eplepsyres.2019.05.013",
language = "English (US)",
volume = "155",
journal = "Epilepsy Research",
issn = "0920-1211",
publisher = "Elsevier",

}

TY - JOUR

T1 - Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency

AU - Hammer, Michael F

AU - Sprissler, Ryan

AU - Bina, Robert W.

AU - Lau, Branden

AU - Johnstone, Laurel

AU - Walter, Christina M.

AU - Labiner, David M

AU - Weinand, Martin E

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Despite recent advances in our understanding of synaptic transmission associated with epileptogenesis, the molecular mechanisms that control seizure frequency in patients with temporal lobe epilepsy (TLE) remain obscure. RNA-Seq was performed on hippocampal tissue resected from 12 medically intractable TLE patients with pre-surgery seizure frequencies ranging from 0.33 to 120 seizures per month. Differential expression (DE) analysis of individuals with low (LSF, mean = 4 seizure/month) versus high (HSF, mean = 60 seizures/month) seizure frequency identified 979 genes with ≥2-fold change in transcript abundance (FDR-adjusted p-value ö0.05). Comparisons with post-mortem controls revealed a large number of downregulated genes in the HSF (1676) versus LSF (399) groups. More than 50 signaling pathways were inferred to be deactivated or activated, with Signal Transduction as the central hub in the pathway network. While neuroinflammation pathways were activated in both groups, key neuronal system pathways were systematically deactivated in the HSF group, including calcium, CREB and Opioid signaling. We also infer that enhanced expression of a signaling cascade promoting synaptic downscaling may have played a key role in maintaining a higher seizure threshold in the LSF cohort. These results suggest that therapeutic approaches targeting synaptic scaling pathways may aid in the treatment of seizures in TLE.

AB - Despite recent advances in our understanding of synaptic transmission associated with epileptogenesis, the molecular mechanisms that control seizure frequency in patients with temporal lobe epilepsy (TLE) remain obscure. RNA-Seq was performed on hippocampal tissue resected from 12 medically intractable TLE patients with pre-surgery seizure frequencies ranging from 0.33 to 120 seizures per month. Differential expression (DE) analysis of individuals with low (LSF, mean = 4 seizure/month) versus high (HSF, mean = 60 seizures/month) seizure frequency identified 979 genes with ≥2-fold change in transcript abundance (FDR-adjusted p-value ö0.05). Comparisons with post-mortem controls revealed a large number of downregulated genes in the HSF (1676) versus LSF (399) groups. More than 50 signaling pathways were inferred to be deactivated or activated, with Signal Transduction as the central hub in the pathway network. While neuroinflammation pathways were activated in both groups, key neuronal system pathways were systematically deactivated in the HSF group, including calcium, CREB and Opioid signaling. We also infer that enhanced expression of a signaling cascade promoting synaptic downscaling may have played a key role in maintaining a higher seizure threshold in the LSF cohort. These results suggest that therapeutic approaches targeting synaptic scaling pathways may aid in the treatment of seizures in TLE.

KW - Hippocampus

KW - Pathway analysis

KW - RNA-seq

KW - Seizure frequency

KW - Temporal lobe epilepsy

UR - http://www.scopus.com/inward/record.url?scp=85066932493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066932493&partnerID=8YFLogxK

U2 - 10.1016/j.eplepsyres.2019.05.013

DO - 10.1016/j.eplepsyres.2019.05.013

M3 - Article

VL - 155

JO - Epilepsy Research

JF - Epilepsy Research

SN - 0920-1211

M1 - 106145

ER -